Affordable Access

Phase II study of erlotinib plus gemcitabine in first-line treatment of poor prognosis, advanced non-small cell lung cancer patients.

Authors
Type
Published Article
Journal
Journal of B.U.ON. : official journal of the Balkan Union of Oncology
Publication Date
Volume
18
Issue
1
Pages
188–194
Identifiers
PMID: 23613405
Source
Medline

Abstract

Statistics

Seen <100 times